R&D Drug Pipeline Database
provides online access to more than 17,000 project entries in all therapeutic
areas and product categories. Each project is specified for its Target or
Mechanism of Action, Product Category, Therapeutic Area, indication and R&D
Phase. Use of the R&D database of marketed and investigational drugs is
intuitive. Data sets of interest can be printed and exported. Projects are
being updated continuously. The R&D history of each project with online
references of information sources can be viewed and printed. Sales figures of
major products are provided. The projects can be segmented into Therapeutic
Areas, Territories, Product Categories and R&D Phases. An advanced search
function allows to combine search parameters. A scroll down menu for predefined
targets conveniently selects projects of interest. By clicking on column
headers, projects can be arranged and listed/displayed in ascending or
descending alphabetical or numerical order, e.g. for R&D phase, product
category or company name.
Benefits from the R&D Drug
Pipeline Database:
- Intuitive use
- Designed for structured searches
- Focused on targets, product categories and R&D phases
- Ideal for competitor analysis (companies, targets, product categories)
- Cost-effective and rapid solution for benchmarking
- Identification of licensing candidates
Project listing in a tabular
format:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Product Category
- Company
- Territory
- Therapeutic Area
- Indication
- R&D Phase
Product Categories:
- Antibody
- Cell
- DNA
- Medical Device / Biomaterial
- Peptide
- Protein
- Radiopharmaceutical
- RNA
- Small Molecule
- Vaccine
- Therapeutic Areas
- Cardiovascular, blood & acute care
- Dermatology
- Gastrointestinal
- Genitourinary, gynecology & renal
- Infectious & toxicology
- Metabolism & endocrine
- Neurology & psychiatry
- Oncology
- Ophthalmolgoy & otorhinolaryngology
- Orthopedics, dental, anesthesia & surgery
- Pulmonary & respiratory
- Rheumatoid & autoimmune
Examples of Predefined Targets
of the Scroll Down Menu:
- Anti-Infective Antibodies
- Antibody-Drug Conjugates (ADC)
- Biologic & Immune Therapy of S. aureus Infections
- c-MET/HGF Inhibitors
- CD20 Antibodies
- Coagulation Factors
- CXCR and CXCL Agonists & Antagonists
- Dengue Virus Vaccines
- EGF-R Agonists and Antagonists
- Enzyme Replacement Therapies
- Erythropoiesis Stimulating Agents
- G-CSF and GM-CSF
- HDAC Inhibitors
- HDL Raising Therapies
- Heat shock protein 90 (Hsp90) Inhibitors
- HPV Vaccines
- Human Growth Hormone
- IGF-1R Antagonists
- Insulin
- Interferon
- Interleukin-17 and IL-17R Antagonists
- Janus Kinase (JAK) Inhibitors
- Malaria Vaccines
- NGF Agonists & Antagonists
- Novel Mitotic Kinase Inhibitors
- PDGF-R Agonists and Antagonists
- PI3K-AKT-mTOR Inhibitors
- Ras-Raf-MEK-ERK Inhibitors
- Targeted Therapy of Hepatitis C
- TGF-R Agonists and Antagonists
- TNF Agonists & Antagonists
- Toll-Like Receptor (TLR) Agonists and Antagonists
- VEGF and VEGF-R Agonists and Antagonists
Know more
about this report at – http://mrr.cm/ZvY
Find all Pharma and
Healthcare
Reports at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.